Representatives From Change Healthcare, Flatiron Health, and Tempus to Discuss Significance of Paper’s Recommendations at 12:00 p.m. ET
WASHINGTON (February 17, 2022)
In a white paper published this morning titled Using Health Data to Advance Personalized Medicine: Challenges and a Path Forward, the Personalized Medicine Coalition (PMC) emphasizes that clinicians and researchers will have unprecedented opportunities in the coming years to accelerate the pace of biomedical progress by aggregating and analyzing data generated by patients during their encounters with the health care system and, increasingly, during their routine engagements with a digitally connected world. Developed by Innovation Horizons Founder Gregory Downing, D.O., Ph.D., in collaboration with a cross-sector working group co-chaired by three PMC board members including Change Healthcare Executive Vice President Kris Joshi, Ph.D., Tempus Senior Vice President of External Affairs Lauren Silvis, J.D., and Flatiron Health Chief Medical Officer Michael Vasconcelles, M.D., the paper envisions an era in which health care decision-makers use data about each patient’s biological characteristics, behaviors, and environmental circumstances to help direct the right interventions to the right patients at the right time.
To put the United States in position to take full advantage of this emerging era of data-driven personalized medicine, the paper encourages policymakers to adopt public policies designed to enhance the utility of electronic health records, protect patient privacy while enabling innovation, and encourage the widespread adoption of real-world data across the health care system.
“In addition to outlining the opportunity to employ data in the future to improve health care, Using Health Data to Advance Personalized Medicine: Challenges and a Path Forward outlines obstacles we must address to ensure that the health system is well-positioned to get the right health care interventions to the right patients at the right time, thereby realizing the extraordinary promise of personalized medicine for patients and health systems,” said PMC President Edward Abrahams.
PMC will explore the significance of the paper’s recommendations today during a 60-minute virtual discussion featuring Downing, Joshi, Silvis, and Vasconcelles. The session is scheduled to begin at 12:00 p.m. ET. Click here to register.
Christopher J. Wells
About the Personalized Medicine Coalition:
The Personalized Medicine Coalition, a 501(c)3 organization comprised of 14 distinct stakeholder groups within health care, promotes the understanding and adoption of personalized medicine concepts, services and products to benefit patients and the health system.